New hope for aggressive liver cancer: major trial tests powerful drug combos
NCT ID NCT05198609
First seen Jan 25, 2026 · Last updated Apr 20, 2026 · Updated 16 times
Summary
This study is comparing two different drug combinations for people with advanced liver cancer that has spread into a major vein in the liver. Researchers want to see if adding a special type of chemotherapy delivered directly to the liver improves survival and slows cancer growth compared to the two-drug combination alone. The trial involves 214 participants who have not had prior systemic treatment for their cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cancer Center Sun Yat-sen University
Guangzhou, Guangdong, 510060, China
Conditions
Explore the condition pages connected to this study.